Overview
- 9 inspections across 8 sites are on record.
- 41 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2024-06-20.
At a glance
Inspections
9
Sites
8
Observations
41
Career since
Feb 2016
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Binex Co., Ltd | 20 Jun 2024 | Human Drugs | On file |
| Apotex Research Private Limited | 15 Mar 2024 | Human Drugs | View 483 → |
| Intas Pharmaceuticals Limited | 7 Dec 2023 | Human Drugs | On file |
| Dr. Reddy's Laboratories Limited | 28 Jan 2020 | Human Drugs | On file |
| LSNE-Leon, SLU, D/B/A: PCI Pharma Services | 16 Oct 2018 | Human Drugs | On file |
Sites inspected
Binex Co., LtdYeonsu, Korea (the Republic of)1 insp.
Apotex Research Private LimitedBengaluru, India1 insp.
Intas Pharmaceuticals LimitedMoraiya, India1 insp.
Dr. Reddy's Laboratories LimitedSrikakulam, India1 insp.
LSNE-Leon, SLU, D/B/A: PCI Pharma ServicesLeon, Spain1 insp.
Co-investigators
Investigators who share inspections with this person.
Thuy T Nguyen2 shared
Della Shin1 shared
Melissa D Ray1 shared
Richmond K Yip1 shared
Jeffrey P Raimondi1 shared
Hyung-Yul Lee1 shared
Jeanne M Fringer1 shared
Dipesh K Shah1 shared
Kham Phommachanh1 shared
Steven P Donald1 shared
Full investigator report
Get the verbatim findings behind Aditi Thakur's 41 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site